Experts
Clients
Startups
Investors
Ambassadors
Circles
OVERVIEW
Sign in Sign up
Sustainable Business Models
Research Group in Business Strategy & Planning
 
R-GPT SUMMARY
Newsfeed
Members
Resources (193)
Ambassador
Opportunities and risks of internet of things (IoT) technologies for circular bu ...
Posted by Mark Field in Business Strategy & Planning and Sustainable Business Models

Systematic Review

Commerce

Internet

Internet of Things*

Investments

Software

In recent years, circular business models (CBM) have become an inevitable requirement to foster improvements in environmental performance. However, the current literature rarely discusses th....
Business models for primary health care delivery in low- and middle-income count ...
Posted by Mark Field in Business Strategy & Planning and Sustainable Business Models

Child

Delivery of Health Care

Developing Countries*

Entrepreneurship

Humans

Primary Health Care

Telemedicine*

Background: Social enterprises are organizations created to address social problems that use business models to sustain themselves financially. Social enterprises can help increase access to....
Business Venturing in Regulated Markets-Taxonomy and Archetypes of Digital Healt ...
Posted by Mark Field in Business Strategy & Planning and Sustainable Business Models

Commerce*

Delivery of Health Care / economics

Digital Health

Digital Technology

European Union*

Humans

Background: Digital health technology (DHT) has the potential to revolutionize the health care industry by reducing costs and improving the quality of care in a sector that faces significant....
Analysing stratified medicine business models and value systems: innovation-regu ...
Posted by Mark Field in Business Strategy & Planning and Sustainable Business Models

Commerce / legislation & jurisprudence*

Cooperative Behavior

Drug Discovery

Humans

Models, Economic*

Social Control, Formal*

Therapies, Investigational / economics*

Stratified medicine offers both opportunities and challenges to the conventional business models that drive pharmaceutical R&D. Given the increasingly unsustainable blockbuster model of drug....